A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults

Completed · Phase 1/Phase 2

Conditions studied: Influenza

In brief

The purpose of this Phase 1/2 study is to generate sufficient safety and immunogenicity data of mRNA-1018 pandemic influenza candidate vaccines in healthy adults ≥18 years of age to enable the initiation of a large Phase 3 trial with one selected vaccine candidate. The study will be conducted in 2 Parts (Part A and Part B) that will enroll and run concurrently. Part A of the study will evaluate 4 vaccine candidates (H5N8, H7N9, H5 only, and H7 only). Part B of the study will evaluate a single vaccine candidate (H5 only-CG).

Key facts

Study ID
NCT05972174
Run by
ModernaTX, Inc.
People needed
1504
Starts
2023-07-10
Expected to finish
2024-07-16
Last updated by the study team
2025-07-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.